The Physician Payments Sunshine Act Legislation Ann Leopold Kaplan October 27, 2008.

Slides:



Advertisements
Similar presentations
Introduction to Existing State Disclosure Laws and Regulations Summit on Disclosure, Transparency and Aggregate Spend For Drug, Device and Biotech Companies.
Advertisements

THE PHYSICIAN PAYMENTS SUNSHINE ACT
Medical Device Law. FDA FDA Regulated Devices From the Beginning Hubbard Electrometer Cases Magnetic Healing Cases Original Law Required Proof of Harm.
Pharmaceutical and Medical Device Manufacturer Conduct Melissa J. Lopes, Deputy General Counsel Massachusetts Department of Public Health.
1 The HIPAA Privacy Rule and Research This presentation will probably involve audience discussion, which will create action items. Use PowerPoint to keep.
HIPAA – Privacy Rule and Research USCRF Research Educational Series March 19, 2003.
HIPAA PRIVACY REQUIREMENTS Dana L. Thrasher Constangy, Brooks & Smith, LLC (205) ; Victoria Nemerson.
1 HIPAA and Research and YOU. 2 INTRODUCTION Rule #1:Don’t Panic Rule #2:Bottom Line for Researchers: HIPAA is Manageable thru Education/Awareness and.
COMPLYING WITH HIPAA PRIVACY RULES Presented by: Larry Grudzien, Attorney at Law.
Marketing to Doctors – Payments for Loyalty Julie Brill Assistant Attorney General Vermont Attorney General ’ s Office Montpelier,
Pharmaceutical Compliance Congress: “State of the States” October 27, 2008 Janice G. Cunningham Jeffrey L. Handwerker.
1 Physician-Industry Transparency: The U.S. Physician Payment Sunshine Act.
Sales & Marketing Compliance Training
Plantemoran.com JANUARY 27, (r) Final Regulations.
An Overview of the Student Loan Practices Code of Conduct Richard W. Buck Associate General Counsel University of North Florida Office of the General Counsel.
Health Care Financial Management Association Sponsored by Emdeon December 22, 2014 Julie A. Simer, Esq. Donald P. Wagner, Esq. Shareholder Of Counsel Buchalter.
Contract Negotiation Basics for Sponsored Programs
2005 FPMP Compliance Training: Physician/Hospital Financial Arrangements Presented by: Brigid M. Maloney, Esq. Brigid M. Maloney, Esq. U.B. Associates.
BIOTECH SUPPLY October 8-9, 2012 Crowne Plaza, Foster City, CA California Transparency in Supply Chain Act, SB 657, Chapter 556, Statutes of 2010 David.
Fraud, Waste & Abuse DEFICIT REDUCTION ACT OF 2005 Presented by: MARCH Vision Care, 2013.
The Third Annual Medical Device Regulatory, Reimbursement and Compliance Congress Compliance Best Practices in a Post Orthopedic Environment David Matyas.
Notice of Privacy Practices Nebraska SNIP Privacy Subgroup July 18, 2002 Michael J. Brown, MHA, CPA Vice-President, Administrative & Regulatory Affairs,
Recent False Claims Developments Robert J. Sherry K&L Gates May 2009.
Open Payments Act AKA the ‘Sunshine Act’ Open Payments Act AKA the ‘Sunshine Act’ Public Postings of Physician Ownership, Investments, & Transfers of Value.
Implementation of Disclosure Legislation in Massachusetts National Disclosure Summit March 6, 2009 Allan Coukell, Director of Policy.
Recent Pricing and Coverage Issues and Their Fraud and Abuse Implications Bill Sarraille
© 2008 Foley Hoag LLP. All Rights Reserved. 1 The New Massachusetts Pharmaceutical & Medical Device Marketing Regulations How to Address and Overcome Likely.
Driving Innovation to Market. Partnering with the Office of Intellectual Property and Industry Sponsored Research December 10, 2013 Tara A. Kamin, Esq.
Patient Protection and Affordable Care Act March 23, 2010.
HIPAA – How Will the Regulations Impact Research?.
Election Funding, Expenditure and Disclosure Forbes Shire Council Local Government By- Election (election of 1 Councillor) 9 May 2015.
1 Pharmaceutical and Medical Device Manufacturer Conduct Melissa J. Lopes, Deputy General Counsel Massachusetts Department of Public Health PHC Meeting.
ESB Copyright 2012 American Fidelity Assurance Company FCCMA June 1, 2012.
Presentation to the Kansas Parity Coalition Andrew Sperling Director of Federal Legislative Advocacy March 19, 2010.
Key Compliance Risks in Clinical Trials Kathleen Meriwether Principal, ERNST & YOUNG, LLP Fraud Investigation & Dispute Services.
OPEN PAYMENTS UF College of Medicine Brown Bag July 23, 2013 Gary Wimsett, Jr., JD.
Understanding the Forces Driving Disclosure Preconference Session First Annual Summit on Sales & Marketing Disclosure for Drug, Device and Biotech Companies.
HIPAA SURVIVAL SKILLS: An Update University of Miami1 Marisabel Davalos, M.S.Ed., CIP Associate Director of Educational Initiatives November, 2008.
Vendor Relations Policy. Why Is There A Policy? The Patient Protection and Affordable Care Act was signed into law March 23, The new law contains.
Health Insurance Portability and Accountability Act (HIPAA) CCAC.
Ethics: How Things Work
WHAT STAKEHOLDERS NEED TO KNOW ABOUT THE CME/SUNSHINE ACT PROVISION OF THE ‘21 ST CENTURY CURES ACT’ JULY 14,
Physicians’ Referrals to Health Care Entities With Which They Have Financial Relationships Exceptions for Certain Electronic Prescribing and Electronic.
1 Harvard University Cambridge, MA March 29, 2007 Medical Device Congress AdvaMed’s Efforts to Promote Compliance Christopher L. White, Esq. Executive.
HIPAA History March 3, HIPAA Ruling Health Insurance Portability Accountability Act Health Insurance Portability Accountability Act Passed by Congress.
March 2010 – IAASB to consider issues paper and task force proposals June 2010 – IAASB first read of exposure draft (prior to next IESBA meeting) September.
Finally, the Final HIPAA/HITECH Regulations are Here! By LYNDA M. JOHNSON Friday, Eldredge & Clark.
California’s New Compliance Law Kelly N. Reeves
Compliance Issues in Dealing With Drug and Device Manufacturers Presentation to The Sixth Annual National Congress On Health Care Compliance Paul E. Kalb,
Final PRIVACY RULE Presentation by Richard Campanelli, Director OCR/HHS at 5 th National HIPAA Summit Washington, D.C. October 31, 2002.
1 Global Codes of Ethics/Conduct Roundtable Discussion International Medical Device Compliance Congress and Best Practices Forum May 27, 2008 Paris Christopher.
Regulation Highlights Kimberly Heifetz May 15, 2012.
Disclosure of Financial Interest Policy. Medical Staff Policy Approved by the MEC’s Aimed at protecting the integrity of the LMHS Medical Staffs Requires.
Juvenile Legislative Update 2013 Confidential Records and Protected Disclosures.
Regulation of Managed Care. Plan for Today Why (and why not) regulate? What is regulated? Who regulates what? Recent developments –Federal insurance market.
Shedding Some Fair Market Value Light on the Sunshine Act
What is HIPAA? HIPAA stands for “Health Insurance Portability & Accountability Act” It was an Act of Congress passed into law in HEALTH INSURANCE.
HIPAA CONFIDENTIALITY
Pharmaceutical Co. Shareholders Perceive that Benefits of Clinical Trials Reporting Exceed Costs Dr. Mina Pizzini, Ph.D. Department of Accounting, McCoy.
Analysis of the Proposed Sunshine Rule: Legal Considerations
The Physician Payments Sunshine Act
Confidential Records and Protected Disclosures
Compliance Program 2018.
2018 Policy and Legislative Update February 18, 2018
The HIPAA Privacy Rule and Research
Lilly Grant Funding Disclosure May 27, 2008
An Introduction to the Sunshine Act
Physician Payments Sunshine Act of 2009 – S. 301
“Netting” Prices Pharmaceutical Compliance Congress November 15, 2004
If it's Subsidized, Get it Authorized: New Restrictions on the Sale and Use of PHI for Marketing Purposes Under HIPAA's Omnibus Rule Angela M. Rust This.
Presentation transcript:

The Physician Payments Sunshine Act Legislation Ann Leopold Kaplan October 27, 2008

Physician Payments Sunshine Act S introduced by Senators Kohl and Grassley, September 2007 HR 5605 introduced by Congressman DeFazio, March 2008 Bills as introduced are very similar but Senate bill has changed since introduction

Physician Payments Sunshine Act: Basics Requires manufacturers to submit reports to HHS disclosing a wide range of payments made directly or indirectly to physicians. Threshold is $25 Requires HHS to post the reports on website that is “easily searchable, downloadable, and understandable.” Imposes significant penalties for failure to report information.

Physician Payments Sunshine Act: A Few Key Issues Scope of reporting- what payments are reportable Thresholds Exemptions Preemption – Federal standard and 50+ state standards?

Physician Payments Sunshine Act: Scope of Requirements S. 2029: Payments or other transfers of value, provided “directly, indirectly, or through an agent, subsidiary, or other third party, to a physician, or to an entity that a physician is employed by, has tenure with, or has an ownership interest in…” Revised Working Draft of Bill: Payments or other transfers of value to a covered recipient or to an entity or individual at the request of or designated on behalf of a covered recipient. Covered recipient defined as a physician or physician medical practice

Physician Payments Sunshine Act: Thresholds S. 2029: $25 Revised Working Draft of Bill: $500 threshold in a year before payments to a particular physician are reported and then all payments above the nominal $25 are reported.

Physician Payments Sunshine Act: Exceptions S. 2029:  Samples  Clinical trial payments  Transfers to physician as patient  De minimus payments ($25 or less)

Physician Payments Sunshine Act: Exceptions Revised Working Draft of Bill:  Samples  Discounts including rebates  Educational materials that are intended for patient use or to benefit patient.  Transfer to physician when physician is patient  Qualitative value of any training or education related to payment or other transfer of value reported that is indicated on the report to be for education.  Loan of a covered device for a short term trial period  Items or services provided under a contractual warranty where the terms of the warranty are set forth in the purchase or lease agreement  De Minimus payments: Anything below $25 in value (increased each year by CPI)  In kind items used for the provision of charity care.

Physician Payments Sunshine Act: Preemption Bills as introduced – no preemption Revised Working Draft of Bill: Preemption included

Draft Preemption Language “The provisions of this section shall preempt any law or regulation of a State or political subdivision of a state relating to disclosure or reporting of information regarding payments or other transfer of value provided to covered recipients by an applicable manufacturer to the State or to any other governmental entity for purposes of including such information in any State- sponsored database or other repository of information."

Proposed Preemption Provision: What Does It Cover? Fairly broad set of state laws or regulations relating to reporting and disclosure requirements of drug and device manufacturers Applies to reporting or disclosure requirements regarding payments or other transfer of value to physicians Payments of all sizes and types

Proposed Preemption: What Might It Not cover? Requirements to report payments to other health care providers? Requirements to report all marketing costs? Bans on gifts or other payments? Prescriber data laws? Code compliance laws?